Carmustine and Cataract - a phase IV clinical study of FDA data

Summary:

Cataract is reported as a side effect among people who take Carmustine (carmustine), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Persantine, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Cataract when taking Carmustine. It is created by eHealthMe based on reports of 4,562 people who have side effects when taking Carmustine from the FDA, and is updated regularly.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

What is Cataract?

Cataract (clouding of the lens inside the eye) is found to be associated with 1,897 drugs and 2,130 conditions by eHealthMe. Check the latest studies of Cataract.

On Apr, 11, 2026

4,562 people reported to have side effects when taking Carmustine.
Among them, 11 people (0.24%) have Cataract.

Among these 11 people:

How long have people been on Carmustine when they have Cataract? *

What is the gender of people who have Cataract when taking Carmustine? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Cataract when taking Carmustine? *

What are other drugs people take besides Carmustine? *

What are other side effects people have besides Cataract? *

Disease Progression: 8 people, 72.73%
Osteopenia (a condition where bone mineral density is lower than normal): 6 people, 54.55%
Corneal Dystrophy (abnormal deposition of substances in the transparent front part of the eye): 6 people, 54.55%
Pain In Jaw: 6 people, 54.55%
Pain In Extremity: 6 people, 54.55%
Dyspnea (difficult or laboured breathing): 6 people, 54.55%
Osteomyelitis (infection of bone): 6 people, 54.55%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 6 people, 54.55%
Oedema Peripheral (superficial swelling): 6 people, 54.55%
Cardiomyopathy (weakening of the heart muscle): 6 people, 54.55%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 6 people, 54.55%
Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 2 people, 18.18%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 18.18%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 18.18%
Lymphoma (cancer that begins in immune system cells): 2 people, 18.18%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 18.18%
Cytomegalovirus Chorioretinitis (infection of choroid and retina of the eye from virus): 2 people, 18.18%
Hodgkin's Lymphoma (cancer originating from white blood cells): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Carmustine and have Cataract?

- Check whether Cataract is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carmustine:

Carmustine (4,562 reports)

Cataract treatments and more:

Cataract (70,564 reports)

Browse all side effects of Carmustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cataract:

Cataract (1,897 drugs)

Browse all the conditions that are associated with Cataract:

Cataract (2,130 conditions)

Related publications that referenced our studies

Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on carmustine (the active ingredients of Carmustine) and Carmustine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.